术前辅以新辅助化疗，术后辅以正规内分泌治疗是提高局部晚期乳腺癌生存率的必要手段。
The neoadjuvant chemotherapy and regular endocrine therapy are the necessary measures to improve the survival rates of locally advanced breast cancer.
乳腺癌术前化疗即新辅助化疗，使局部进展期乳腺癌的治疗取得了重大进展。
Nowadays, neoadjuvant chemotherapy, which is raised by clinic, made a big breakthrough in breast cancer partial treatment progression.
目的：探讨动态增强序列对原发直肠癌患者术前分期的评估价值及直肠癌血液微循环在新辅助治疗前后变化。
Purpose:To determine whether addition of gadolinium-enhanced LAVA sequence to MR routine scan imaging is valuable for preoperative assessment of TN stage in patients with primary rectal cancer.
目的探讨术前新辅助放化疗在可切除食管癌治疗中的作用。
Objective To explore the effect of pre-operative adjuvant chemo-radiotherapy and surgical treatment on resectable esophageal cancer.
结论术前新辅助内分泌治疗在高龄乳腺癌患者中能达到原发病灶和区域淋巴结降期的目的。
Conclusion Preoperative endocrine therapy for breast cancer of elderly women could effectively delay or remit the advancement of the tumor.
目的探讨术前新辅助内分泌治疗在老年乳腺癌治疗中的意义。
Objective To study the curative effect of preoperative endocrine therapy on breast cancer in elderly women.
肿瘤切除术前的新辅助化疗方案现已成为了肝母细胞瘤(HB)的一项主要治疗手段。
Neoadjuvant chemotherapy followed by resection has become the mainstay in the treatment of hepatoblastoma (HB).
肿瘤切除术前的新辅助化疗方案现已成为了肝母细胞瘤(HB)的一项主要治疗手段。
Neoadjuvant chemotherapy followed by resection has become the mainstay in the treatment of hepatoblastoma (HB).
应用推荐